These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2139939

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Study of the intraperitoneal penetration of imipenem/cilastatin in acute peritonitis with perforation].
    Pezé P, Mounier M, Cevallos R, Denis F.
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):504-7. PubMed ID: 2385446
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics and tolerance after repeated doses of imipenem/cilastatin in patients with severe renal failure.
    Verbist L, Verpooten GA, Giuliano RA, Debroe ME, Buntinx AP, Entwistle LA, Jones KH.
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():115-20. PubMed ID: 3469184
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pharmacokinetic evaluation of imipenem combined with cilastatin in cystic fibrosis.
    Bergan T, Michalsen H, Malmborg AS, Pedersen SS, Pressler T, Storrøsten OT, Strandvik B.
    Chemotherapy; 1993 Dec; 39(6):369-73. PubMed ID: 8222862
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin.
    Dreetz M, Hamacher J, Eller J, Borner K, Koeppe P, Schaberg T, Lode H.
    Antimicrob Agents Chemother; 1996 Jan; 40(1):105-9. PubMed ID: 8787889
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Pharmacokinetic and clinical evaluations of imipenem/cilastatin sodium in neonates and premature infants].
    Motohiro T, Sakata Y, Oda K, Kawakami A, Tanaka K, Koga T, Shimada Y, Tomita S, Fujimoto T, Tominaga K.
    Jpn J Antibiot; 1989 May; 42(5):1102-24. PubMed ID: 2664254
    [Abstract] [Full Text] [Related]

  • 34. Dose-dependent kinetics of cilastatin in laboratory animals.
    Lin JH, Chen IW, Ulm EH.
    Drug Metab Dispos; 1989 May; 17(4):426-32. PubMed ID: 2571484
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Imipenem-cilastatin sodium, a broad-spectrum carbapenem antibiotic combination.
    Pastel DA.
    Clin Pharm; 1986 Sep; 5(9):719-36. PubMed ID: 3530614
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.